Northwire Canada EditionSaturday, July 11, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%

Cannabis

Page 10
  1. May 13, 2026 · 08:30 · MDMA · Routine +

    PharmAla Advances APA-01 SPV Deal; Royalty Stream Contingent on Funding

    PharmAla Biotech Executes Definitive Agreement to Form Special Purpose Vehicle, Restora Neurosciences, for Clinical Development of Patented Novel MDXX Molecule APA-01

    01
  2. May 13, 2026 · 07:30 · LABS · Routine +

    MediPharm Labs scrapes to adjusted EBITDA profitability in Q1 2026, but a veteran affairs reimbursement cut looms large over its direct-to-patient business.

    MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA

    02
  3. May 13, 2026 · 07:08 · CWEB · Routine −

    Debt Relief Looms Over Revenue Decline as Liquidity Crunch Precedes Shareholder Vote

    Charlotte's Web First Quarter 2026 Financial Results

    03
  4. May 13, 2026 · 07:00 · VRNO · Routine +

    Verano Executes on Schedule III Pathway as Debt Load Remains Primary Risk Factor

    Verano Submits DEA Registration Applications for State-Licensed Medical Cannabis Businesses Following Landmark Federal Rescheduling Order

    04
  5. May 13, 2026 · 05:16 · BAMM · Routine +

    Asset Monetization Strategy Confirms Liquidity but Organic Growth Remains Stagnant

    Body and Mind closes New Jersey equity interest deal

    05
  6. May 12, 2026 · 16:39 · IAN · Routine −

    Revenue Decline and EBITDA Miss Signal Operational Stagnation Despite Expansion

    iAnthus Reports Fiscal First Quarter 2026 Financial Results

    06
  7. May 12, 2026 · 16:28 · BAMM · Routine +

    Portfolio Optimization via NJ Divestiture

    Body and Mind Provides Corporate Update

    07
  8. May 12, 2026 · 16:05 · JUSH · Routine +

    Jushi Stabilizes Balance Sheet with High-Cost Debt as Margin Expansion Offsets Persistent Net Losses

    Jushi Holdings Inc. Reports First Quarter 2026 Financial Results

    08
  9. May 12, 2026 · 16:05 · GRIN · Material +

    Grown Rogue lifts revenue forecast as New Jersey ramp outruns legacy market headwinds

    Grown Rogue Reports First Quarter 2026 Results

    09
  10. May 12, 2026 · 07:30 · VREO · Routine +

    Vireo’s acquisition feast lifts revenue tenfold, but a glut of new shares keeps the stock on a starvation diet below a dollar.

    Vireo Growth Inc. Announces First Quarter 2026 Results

    10
  11. May 12, 2026 · 07:00 · TLRY · Routine +

    Tilray Brands Launches New IPA Amidst Beverage Portfolio Expansion; Stock Retreats from Cannabis Rescheduling Highs

    Blue Point Brewing Launches Magic Hour IPA-A Bright, Tropical 6% ABV Sipper for Golden Hour

    11
  12. May 12, 2026 · 06:00 · OGI · Material −

    Organigram’s core Canadian business stumbles into the red just as its landmark Sanity Group deal closes, leaving investors to wonder if the European cure will be enough to offset domestic decay.

    Organigram Reports Second Quarter Fiscal 2026 Results

    12
  13. May 12, 2026 · 03:02 · HERB · Routine +

    Northern Drip Launch Marks Incremental Brand Expansion Amidst Persistent Cash Burn and Dilution Overhang

    Herbal Dispatch Expands House of Brands Strategy with Launch of Northern Drip Extracts

    13
  14. May 11, 2026 · 16:02 · LEEF · Routine +

    LEEF Brands Secures Expansion Capital as Margins Surge to Record Levels

    LEEF Brands Closes Final Round of Oversubscribed US$9.3 Million Financing

    14
← Newer Older →